The Department of Health and Human Services and other federal agencies should work through the Biodefense Steering Committee to ensure the Biodefense Coordination Team defines the capabilities needed to prepare for and respond to significant biological incidents such as COVID-19; monitors and reports on findings from interagency exercises and real-world incidents; and recommends action to address identified challenges, according to a report released today by the Government Accountability Office. The Coronavirus Aid, Relief, and Economic Security Act called for GAO to review federal efforts to prepare for, respond to and recover from COVID-19. The agency reviewed interagency response plans and exercises and real biological incidents between 2009 and 2019 to identify opportunities to better achieve National Biodefense Strategy objectives.

Related News Articles

Headline
Flu cases are growing or likely growing in 39 states, according to the latest Centers for Disease Control and Prevention data from Nov. 11. COVID-19…
Headline
The Food and Drug Administration yesterday published an announcement from Otsuka ICU Medical saying that the company issued a voluntary recall for a mislabeled…
Headline
A study published Oct. 30 by the American Heart Association found that people have an elevated risk of heart attack and stroke following flu and COVID-19…
Headline
The Centers for Disease Control and Prevention will update its immunization schedules for the COVID-19 and chickenpox vaccines to adopt recent recommendations…
Headline
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…
Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…